RB

Rakesh Baban Doifode

Director Director DIN 01918587
DIN 01918587 First appointment Dec 2010 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2010
Shareholding value Locked Premium profile

About Rakesh Baban Doifode

Rakesh Baban Doifode has 15 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 01918587
Primary Designation Director
First Appointment 26 Dec 2010
Oldest Company Age 15 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Era Medicine Private Limited U33110MH2010PTC211370
Director 26 Dec 2010 2010 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Era Medicine Private Limited
Premium access

Shareholding and investment profile for Rakesh Baban Doifode

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Baban Doifode

Rakesh Baban Doifode has 15 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Rakesh Baban Doifode is associated with 0 companies as Director.

Rakesh Baban Doifode has expertise in General Business.

Rakesh Baban Doifode has 15 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available